Free Trial

Better Therapeutics (BTTX) Insider Trading & Ownership

Better Therapeutics logo
$0.0001 0.00 (0.00%)
As of 05/14/2026 12:23 PM Eastern

Better Therapeutics (NASDAQ:BTTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
51.40%
Number Of
Insiders Buying
(Last 3 Years)
5
Amount Of
Insider Buying
(Last 3 Years)
$1.24M
Number Of
Insiders Selling
(Last 3 Years)
0
Get BTTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Better Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTTX Insider Buying and Selling by Quarter

Better Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2023Buy274,010$0.73$200,027.30  
7/27/2023
David P Perry
Chairman
Buy1,233,045$0.73$900,122.85  
7/27/2023
Frank Karbe
CEO
Buy137,005$0.73$100,013.65  
7/27/2023
Mark A Berman
Insider
Buy54,802$0.73$40,005.46  
5/16/2023Buy600$0.87$522.00  
(Data available from 1/1/2013 forward)

BTTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Better Therapeutics includes Andrew J Armanino, David P Perry, Elder Granger, Frank Karbe, and Mark A Berman. Learn more on insiders at BTTX.

51.40% of Better Therapeutics stock is owned by insiders. Learn more on BTTX's insider holdings.



This page (NASDAQ:BTTX) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners